Results 171 to 180 of about 20,777 (183)

Real-World Evidence for Existing Anti-Obesity Therapies-The Realities of Treatment Adherence, Tolerability, Access and Patient Satisfaction. [PDF]

Diabetes Obes Metab
Kassem S.
europepmc   +1 more source

Effect of Naltrexone HCl and Bupropion HCl (Contrave) Extended-Release Tablet (NB-ER) for Weight Maintenance in Adult Patients After a 6-Month Intensive Behaviour Modification Program Combined With Meal Replacements. [PDF]

Clin Obes
Chetty VT, Denescu L, Zevin B, Damjanovic S, Balodis IM, Elsharif A, Foster G.   +6 more
europepmc   +1 more source

High Prevalence and Low Incidence of Constipation Among Glucagon-Like Peptide-1 Receptor Agonist Users. [PDF]

Clin Gastroenterol Hepatol
Chang M, Wang K, Berschback M, Staller K.   +3 more
europepmc   +1 more source

Design of INFORMUS, a pragmatic, randomized, double-blind, placebo-controlled study of cardiovascular outcomes with the extended-release, fixed-dose combination of naltrexone and bupropion. [PDF]

Obes Pillars
Kyle M, Savastano DM, Sharpe TA, Kelly B.   +3 more
europepmc   +1 more source

Task-aligned outcome learning in psychiatry: reducing endpoint dilution. [PDF]

Front Psychiatry
Strobl EV.
europepmc   +1 more source

Utilization and adherence to smoking cessation pharmacotherapy: A population-based study in Spain. [PDF]

Aten Primaria
Majo García R, Díaz Madero A, Díez Flecha C, Martínez Tahoces SM, Fernández-Martínez MN, Fernández-García D.   +5 more
europepmc   +1 more source

Two-Year Biomarker Trends and Kidney/Mortality Outcomes After Semaglutide Versus Phentermine-Topiramate and Naltrexone-Bupropion in People With Obesity and Without Diabetes. [PDF]

Am J Ther
Chen SC, Liu KW, Huang YN, Meyerowitz-Katz G, Su PH.   +4 more
europepmc   +1 more source